- Home
- GTX vs RNA Comparison
GTX vs RNA Comparison
Compare GTX & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GTX | RNA |
|---|---|---|
| Founded | 2018 | 2012 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.0B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | GTX | RNA |
|---|---|---|
| Price | $18.38 | $72.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 20 |
| Target Price | $20.00 | ★ $69.26 |
| AVG Volume (30 Days) | ★ 2.4M | 1.9M |
| Earning Date | 02-19-2026 | 02-26-2026 |
| Dividend Yield | ★ 1.67% | N/A |
| EPS Growth | ★ 55.30 | N/A |
| EPS | ★ 1.57 | N/A |
| Revenue | ★ $3,537,000,000.00 | $20,868,000.00 |
| Revenue This Year | $3.71 | $57.30 |
| Revenue Next Year | $3.11 | $28.41 |
| P/E Ratio | $12.22 | ★ N/A |
| Revenue Growth | N/A | ★ 106.27 |
| 52 Week Low | $7.02 | $21.51 |
| 52 Week High | $19.27 | $72.70 |
Technical Indicators
Market Signals| Indicator | GTX | RNA |
|---|---|---|
| Relative Strength Index (RSI) | 59.25 | 72.72 |
| Support Level | $18.52 | $72.23 |
| Resistance Level | $19.09 | $72.70 |
| Average True Range (ATR) | 0.51 | 0.17 |
| MACD | 0.07 | -0.14 |
| Stochastic Oscillator | 65.15 | 74.29 |
Price Performance
Historical ComparisonAbout GTX Garrett Motion Inc.
Garrett Motion Inc designs, manufactures and sells engineered turbocharger and electric-boosting technologies for light and commercial vehicle original equipment manufacturers (OEMs). The company is a technology leader with expertise in delivering products across gasoline, diesel, natural gas and electrified powertrains. The company also sells its technologies in the aftermarket through its distribution network. The company derives maximum of its revenue from Gas and geographically from Europe.
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.